We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cardiac MR Aids in the Prevention of Sudden Cardiac Death

By HospiMedica International staff writers
Posted on 14 Sep 2011
European scientists have developed a technique to identify a subgroup of patients with myocardial infarction that is at increased risk for sudden cardiac death. More...
Using cardiac magnetic resonance tomography (CMR), the scientists are able to detect the extent of infarction-related damage to the heart muscle and assess the risk for life-threatening arrhythmias.

The investigators of the research were from the Charite-Universitätsmedizin Berlin (Germany) and Universität Leiden (The Netherlands), and the study’s findings were published August 2011 in the Journal of the American College of Cardiology.

Myocardial infarction frequently leads to permanent complications such as arrhythmias, heart insufficiency, or heart failure. Physicians refer to this as chronic myocardial infarction. A chronically ill heart muscle frequently works with a severely decreased function and is at higher risk to develop dangerous arrhythmias that can lead to sudden cardiac death. To prevent this, patients usually receive an implantable cardioverter-defibrillator (ICD). This device, which is implanted like a pacemaker, detects dangerous arrhythmias and delivers an electric shock to the heart muscle. In consequence, normal sinus rhythm is reestablished.

As it is difficult to predict who is really going to develop life-threatening arrhythmias after a myocardial infarction, physicians implant more preventive ICDs than needed. This results in a higher quantity of complications for patients and an enormous burden on national health systems. Therefore, the aim of the present study was to identify a method to improve the evaluation of individual risk for developing dangerous arrhythmias.

Prof. Jeannette Schulz-Menger and her team from the Experimental and Clinical Research Center (ECRC) of Charité and HELIOS-Krankenhaus Berlin Buch (Germany) examined 52 chronic myocardial infarction patients with CMR. With the use of contrast agents they were able to assess how much of the heart muscle was affected by the infarction. After ICD implantation, there was a significant association demonstrated between relative infarct mass and development of arrhythmias. The depth of the scarred tissue in the heart muscle, the transmurality, provided the best prediction. “We found a parameter that offers the chance to predict the individual risk for sudden cardiac death,” explained Prof. Schulz-Menger. “We hope to be able to supply every patient with the adequate therapy and avoid unnecessary costs and complications,” stated Dr. Philipp Boyé, first author of the study.

Related Links:
Charite-Universitätsmedizin Berlin
Universität Leiden
HELIOS-Krankenhaus Berlin Buch



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.